Page 33 - Read Online
P. 33

Moriguchi et al. Hepatoma Res 2019;5:43                          Hepatoma Research
               DOI: 10.20517/2394-5079.2019.20




               Review                                                                        Open Access


               Epidemiology of hepatocellular carcinoma in
               nonalcoholic fatty liver disease



               Michihisa Moriguchi, Yuya Seko, Aya Takahashi, Yoshito Itoh

               Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of
               Medical Science, Kyoto 602-8566, Japan.
               Correspondence to: Dr. Michihisa Moriguchi, Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural
               University of Medicine Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-
               8566, Japan. E-mail: mmori@koto.kpu-m.ac.jp
               How to cite this article: Moriguchi M, Seko Y, Takahashi A, Itoh Y. Epidemiology of hepatocellular carcinoma in nonalcoholic fatty
               liver disease. Hepatoma Res 2019;5:43. http://dx.doi.org/10.20517/2394-5079.2019.20
               Received: 15 Oct 2019    First Decision: 18 Nov 2019    Revised: 4 Dec 2019    Accepted: 17 Dec 2019    Published: 26 Dec 2019

               Science Editor: Darrell Crawford    Copy Editor: Jing-Wen Zhang    Production Editor: Jing Yu


               Abstract
 Received:     First Decision:     Revised:     Accepted:    Published:
               Along with the changes in our food culture and lifestyle, conditions such as obesity, diabetes mellitus, and metabolic
 Science Editor:     Copy Editor:     Production Editor: Jing Yu   syndrome have been on the rise, and the incidence of nonalcoholic fatty liver disease (NAFLD), which is closely
               related to these diseases, has also increased rapidly. Despite being a risk factor for the development of hepatocellular
               carcinoma (HCC), NAFLD has no established screening method, and HCC originating from NAFLD often tends to be
               discovered in its advanced and symptomatic stages, which has become an important clinical problem. Even though
               the carcinogenicity rate among the entire population of NAFLD patients is not high compared to that of patients
               with viral hepatitis, since HCC also often develops from non-cirrhotic livers, it is difficult to narrow down the cases
               that need to be under surveillance. Going forward, it will be important to clarify the clinical characteristics and
               genetic background of NAFLD-related HCC and establish not only a useful surveillance method but also preventive
               methods.

               Keywords: Hepatocellular carcinoma, nonalcoholic fatty liver disease, epidemiology




               INTRODUCTION
               Hepatocellular carcinoma (HCC) is the seventh most common type of cancer worldwide and the second
                                                    [1]
               most common cause of cancer-related death . Although the majority of cases are caused by viruses such as


                           © The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                        www.hrjournal.net
   28   29   30   31   32   33   34   35   36   37   38